Title
Category
Credits
Event date
Cost
  • Participation
$0.00
Acute Myeloid Leukemia (AML) is an aggressive hematologic malignancy that affects approximately 20,000 patients each year in the United States. Management of AML has changed little over the last several decades and outcomes remain unsatisfactory. However, recent drug discoveries and approvals show tremendous promise. This presentation will review the current treatment armamentarium of AML highlighting novel concepts and investigational agents in development.
  • NCPD/CNE
  • Participation
$0.00
Ali Shazib, DMD, will highlight the field of oral medicine and its integration into the oncology landscape (oral oncology), identify oral complications associated with cancer therapies, practical approaches towards managing oral complications, and discuss the role of multi-disciplinary care through going through cases. The presentation will include challenges associated with oral care for patients undergoing cancer therapy and its role in survivorship and beyond.